| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 06/13/2001 | EP1105413A2 Hepatitis c inhibitor tri-peptides |
| 06/13/2001 | EP1105412A1 Serine protease inhibitors comprising alpha-keto heterocycles |
| 06/13/2001 | EP1105404A1 Purification of oligomers using dual-end selection |
| 06/13/2001 | EP0789776B1 Nucleic acid transfer system |
| 06/13/2001 | CN1299372A Novel aspartame derivative crystal and process for producing same |
| 06/13/2001 | CN1299371A Novel aspartame derivative crystal and process for producing same |
| 06/13/2001 | CN1299241A Sweetener compositions |
| 06/13/2001 | CN1299240A Novel sweetener compositions |
| 06/12/2001 | US6245938 4-pentenoyl groups for derivatization and protection of amino acids |
| 06/12/2001 | US6245934 Reacting n-protected aspartylphenylalanine methyl ester in aqueous medium and in the presence of alcohol with acesulfamic acid and precipitating the salt formed |
| 06/12/2001 | US6245764 β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
| 06/12/2001 | US6245763 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/12/2001 | US6245746 Administering amide microbiocide antibiotic |
| 06/12/2001 | US6245743 Inhibitors of factor Xa |
| 06/12/2001 | US6245742 Antitumor, anticarcinogenic and antimetastasis agents; viricides, psoriasis, antiinflammatory agents, antiallergens, psoriasis |
| 06/12/2001 | US6245738 Cytokine restraining agents |
| 06/12/2001 | US6245502 Target system |
| 06/12/2001 | US6245359 Active agent transport systems |
| 06/12/2001 | CA2171453C Glutathione analogs and paralog panels comprising glutathione mimics |
| 06/12/2001 | CA2044978C Platelet-aggregation inhibitor |
| 06/12/2001 | CA1341250C Method for inducing biological coverings in wounds |
| 06/07/2001 | WO2001040263A1 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040262A1 Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease |
| 06/07/2001 | WO2001040204A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040180A2 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents |
| 06/07/2001 | WO2001010894A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 06/07/2001 | US20010003001 Compounds and compositions for delivering active agents |
| 06/07/2001 | CA2392713A1 Novel antidiabetic agents |
| 06/07/2001 | CA2390349A1 Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease |
| 06/06/2001 | EP1104887A2 A method and test kit for assaying collagen fragments in body fluids |
| 06/06/2001 | EP1104755A1 Process for the preparation of (S)-N-tertbutyl-1,2,3,4- tetrahydroisoquinoline-3-carboxamide |
| 06/06/2001 | EP1104304A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 06/06/2001 | CN1298387A Process for the preparation of methyl (2S)-2-[(3R)-3-CN-[tert-butyloxycarbonyl]-amino)-2-oxopyrrolidin-1-yL] propionate |
| 06/06/2001 | CN1066773C Enzymatic coupling of L-phenylalanine methyl ester and N-benzyloxycarbonyl-aspartic acid |
| 06/06/2001 | CN1066712C Prolineamide derivatives |
| 06/05/2001 | US6242432 Antihypertensive activity, antihypersensitive activity; treatment of cardiovascular disease |
| 06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 06/05/2001 | US6242416 Inhibition of β-amyloid binding to the p75 nerve growth factor receptor |
| 06/05/2001 | US6241965 Somatostatin derivatives and their radiolabelled products |
| 06/05/2001 | CA2059647C Thiocylating reagents and intermediates, thiopeptides, and methods for preparing and using same |
| 05/31/2001 | WO2001038584A2 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 05/31/2001 | WO2001038297A1 Novel intermediate for sweetener with high sweetness and process for producing the same |
| 05/31/2001 | WO2000077032A3 Spermine:peptide-based surfactant compounds |
| 05/31/2001 | WO2000075172A3 Factor viia inhibitors |
| 05/31/2001 | WO2000069472A3 Enzyme-activated anti-tumor prodrug compounds |
| 05/31/2001 | WO2000042071A3 Compounds and methods to inhibit or augment an inflammatory response |
| 05/31/2001 | WO1999024553A9 X-ray crystal comprising hiv-1 gp120 |
| 05/31/2001 | US20010002422 (3,4,7,8,9,10-hexahydro-6, 10 -6H-pyridazino [1,2-a] [1,2,] diazepine-1-carboxylic-acid derivatives |
| 05/30/2001 | EP1103560A1 Novel thiazolidine derivatives |
| 05/30/2001 | EP1102789A1 Monocyclic compounds having nk-2 antagonist action and compositions containing them |
| 05/30/2001 | EP1102763A2 Fsh mimetics for the treatment of infertility |
| 05/30/2001 | EP0914334B1 Process and intermediates for the synthesis of lhrh antagonists |
| 05/30/2001 | EP0879243B1 (n)-(s)-1-phenyl-1-alkanamide (n)-(3,3-dimethylbutyl)-l-aspartyl-d-alpha aminoalkanoic acid for use as a sweetener |
| 05/30/2001 | CN1297453A Certain thiol inhibitors of endothelin-converting enzyme |
| 05/30/2001 | CN1297354A Dipeptide caspase inhibitors and use thereof |
| 05/30/2001 | CN1066329C Preparation of drug composition |
| 05/29/2001 | US6240336 Control unit for an irrigation system |
| 05/29/2001 | US6239150 Penicillaminamide derivatives |
| 05/29/2001 | US6239111 Drug for treating brain diseases, enables prevention or treatment of dementia and similar diseases caused by degeneration or sloughing of neurons, an ally sulfide, sulfoxide or sulfone |
| 05/29/2001 | US6239108 Cell adhesion inhibitors |
| 05/29/2001 | US6239107 Treatment of male impotence or treatment of neurodegenerative diseases |
| 05/29/2001 | US6239104 Isolated and purified substance which inhibits neoplastic cell growth denominated dolastatin 16 |
| 05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
| 05/29/2001 | CA2218031C Plant cell growth factor |
| 05/29/2001 | CA2214410C Peptide and a method of obtaining it |
| 05/25/2001 | WO2001037194A2 Crystallizable compositions comprising a caspase-7 |
| 05/25/2001 | WO2001036454A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 05/25/2001 | WO2001036451A1 Vitamin e derivatives |
| 05/25/2001 | WO2001036450A1 S-allylmercaptoglutathione and uses thereof |
| 05/25/2001 | WO2001036006A1 Opioid metallopeptide compositions and methods |
| 05/25/2001 | WO2001000656A3 Novel indazole peptidomimetics as thrombin receptor antagonists |
| 05/25/2001 | CA2391969A1 S-allylmercaptoglutathione and uses thereof |
| 05/25/2001 | CA2389569A1 Crystallizable compositions comprising a caspase-7 |
| 05/23/2001 | EP1101499A2 Diagnostic agents for pancreatic exocrine function |
| 05/23/2001 | EP1100928A2 Enzymes for biopolymer production |
| 05/23/2001 | EP1100824A1 Compounds with growth hormone releasing properties |
| 05/23/2001 | EP1100814A2 Inhibitors of urokinase and blood vessel formation |
| 05/23/2001 | EP1100782A1 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof |
| 05/23/2001 | EP1100773A1 Saturated and unsaturated abietane derivatives, derived conjugates and uses in a diagnostic composition, a reagent and a device |
| 05/23/2001 | EP1100759A1 Transition metal complexes as linkers |
| 05/23/2001 | EP1100520A1 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 05/23/2001 | EP0722431B1 Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
| 05/23/2001 | CN1296493A Aspartyl dipeptide ester derivatives and sweeteners |
| 05/22/2001 | US6235929 Tripeptide α-ketoamides |
| 05/22/2001 | US6235922 Processes and intermediates for preparing benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP |
| 05/22/2001 | US6235899 Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds |
| 05/22/2001 | US6235877 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 05/22/2001 | US6235876 Liquid phase process for the preparation of GNRH peptides |
| 05/22/2001 | US6235755 FSH mimetics for the treatment of infertility |
| 05/22/2001 | US6235717 Pharmaceutical compounds |
| 05/22/2001 | US6235707 Anticoagulant peptidyl-arginine aldehyde derivatives |
| 05/17/2001 | WO2001034631A2 PEPTIDE ANALOGS AND MIMETICS SUITABLE FOR IN VIVO USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ABNORMAL PROTEIN FOLDING INTO AMYLOID, AMYLOID-LIKE DEPOSITS OR β-SHEET RICH PATHOLOGICAL PRECURSOR THEREOF |
| 05/17/2001 | WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 05/17/2001 | WO2001034171A2 Peptides for treatment of erectile dysfunction |
| 05/17/2001 | WO2001010890A3 Process of synthesis of fluorescent protease substrates |
| 05/17/2001 | US20010001309 For treating pathologies related to altered alpha v beta 3 integrin-mediated cell attachment, in particular wherein inhibition of angiogenesis is desired, for example in tumors, also associated with metastasis |
| 05/17/2001 | DE19952956A1 Verfahren zur Verbindung von molekularen Substanzen A method for connection of molecular substances |
| 05/17/2001 | CA2390854A1 Peptides for treatment of erectile dysfunction |
| 05/17/2001 | CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 05/17/2001 | CA2389041A1 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or .beta.-sheet rich pathological precursor thereof |